1 – 10 of 20
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Fetal and neonatal alloimmune thrombocytopenia in 2022 : a response
(
- Contribution to journal › Letter
-
Mark
An HPA-1a–positive platelet–depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia : a randomized, single-blind, placebo–controlled, single-center, phase 1/2 proof-of-concept study
(
- Contribution to journal › Article
- 2022
-
Mark
Antenatal intravenous immunoglobulins in pregnancies at risk of fetal and neonatal alloimmune thrombocytopenia : comparison of neonatal outcome in treated and nontreated pregnancies
(
- Contribution to journal › Article
- 2020
-
Mark
Fetal/neonatal alloimmune thrombocytopenia : A systematic review of impact of HLA-DRB3∗01:01 on fetal/neonatal outcome
(
- Contribution to journal › Scientific review
-
Mark
Foetal and neonatal alloimmune thrombocytopenia – The role of the HLA-DRB3*01:01 allele for HPA-1a-immunisation and foetal/neonatal outcome
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Risk of HPA-1a–immunization in HPA-1a–negative women after giving birth to an HPA-1a–positive child
(
- Contribution to journal › Article
-
Mark
Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia : a systematic review
(
- Contribution to journal › Article
-
Mark
Postnatal intervention for the treatment of FNAIT : a systematic review
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Screening for fetal and neonatal alloimmune thrombocytopenia - lessons learned from a Norwegian screening program
(
- Contribution to journal › Letter
-
Mark
Determination of fetal RHD type in plasma of RhD negative pregnant women
(
- Contribution to journal › Article